SOLIGENIX, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SOLIGENIX, INC. stock issued during period, value, other for the quarter ending 2021-03-31 was -$539.90K.
- SOLIGENIX, INC. stock issued during period, value, other for the quarter ending 2020-12-31 was $0.00.
- SOLIGENIX, INC. stock issued during period, value, other for the quarter ending 2020-09-30 was $0.00.
- SOLIGENIX, INC. stock issued during period, value, other for the quarter ending 2020-06-30 was $5.17M.
- SOLIGENIX, INC. stock issued during period, value, other for fiscal 2020 was $5.00M.
- SOLIGENIX, INC. stock issued during period, value, other for fiscal 2018 was $38.40K, a 66.88% decline from fiscal 2017.
- SOLIGENIX, INC. stock issued during period, value, other for fiscal 2017 was $115.93K, a 93.23% decline from fiscal 2016.
- SOLIGENIX, INC. stock issued during period, value, other for fiscal 2016 was $1.71M, a 27.86% increase from fiscal 2015.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2021-03-31 | -$539.90K 10-Q · filed 2021-05-18 | $4.63M derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $5.00M 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | |
| 2020-06-30 | $5.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | |
| 2020-03-31 | -$174.72K 10-Q · filed 2021-05-18 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $38.40K 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $38.40K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $18.60K 10-Q · filed 2019-08-13 | $131.23K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $19.80K 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $115.93K 10-K · filed 2019-03-26 |
| 2017-09-30 | $92.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | |
| 2016-12-31 | $73.21K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.71M 10-K · filed 2018-03-15 |
| 2016-09-30 | $676.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2015-12-31 | $224.15K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $1.34M 10-K · filed 2017-03-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.12M derived: sum of 4 quarters · filed 2016-03-24 |
| 2015-06-30 | $868.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $1.27M derived: sum of 4 quarters · filed 2016-03-24 |
| 2015-03-31 | $246.53K 10-Q · filed 2015-05-14 | $558.75K derived: sum of 4 quarters · filed 2016-03-24 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $470.48K 10-K · filed 2016-03-24 |
| 2014-09-30 | $156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | |
| 2014-06-30 | $156.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | |
| 2014-03-31 | $158.25K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $528.05K 10-K · filed 2015-03-25 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $355.00K 10-K · filed 2013-02-26 |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | |
| 2010-12-31 | $70.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |